FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 111 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71 | +1.4% | 15,900 | -25.0% | 0.00% | – |
| Q2 2023 | $70 | -32.7% | 21,200 | -41.9% | 0.00% | – |
| Q1 2023 | $104 | -90.5% | 36,461 | -75.8% | 0.00% | – |
| Q4 2022 | $1,095 | -99.7% | 150,509 | +237.4% | 0.00% | – |
| Q3 2022 | $361,000 | +147.3% | 44,605 | +50.1% | 0.00% | – |
| Q2 2022 | $146,000 | -75.5% | 29,717 | +17.9% | 0.00% | – |
| Q1 2022 | $596,000 | -75.0% | 25,205 | -81.3% | 0.00% | – |
| Q4 2021 | $2,384,000 | +90.3% | 134,755 | +203.5% | 0.00% | – |
| Q3 2021 | $1,253,000 | – | 44,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |